A new report from Massachusetts cannabis regulators described the past fiscal year – July 2023 to June 2024 – as a “pivotal chapter” for the maturation of the marijuana trade in the state, citing ever-increasing sales records, new social equity developments and upcoming social consumption business licenses. The annual report, …
MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) said its experimental ketamine-based drug outperformed currently available pain treatments in preclinical studies, building on months of research that show why the compound might succeed where other treatments have failed. The drug, known as Ketamir-2, demonstrated up to 112% more effective results than pregabalin (Lyrica) …
Missouri’s cannabis industry generated $1.8 billion in combined sales during its first year of adult-use operations, while the medical market saw dramatic declines following recreational legalization, according to the state’s first comprehensive cannabis report. The Missouri Department of Health and Senior Services reported adult-use sales reached $929.7 million during the …